Mayfair Advisory Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Mayfair Advisory Group's PFE Position: Q3 2025 in Review
Mayfair Advisory Group sold out of Pfizer (PFE) in Q3 2025, closing a stake of 9,862 shares — an estimated $242K sold.
Mayfair Advisory Group first reported a position in PFE in Q3 2020 and held it in 20 quarters. The position peaked at $793K in Q4 2021. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.
- Mayfair Advisory Group reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
- Mayfair Advisory Group sold 9,862 Pfizer shares in Q3 2025, an estimated $242K.
- Mayfair Advisory Group first reported a position in Pfizer in Q3 2020 and held it in 20 quarters.
- Mayfair Advisory Group's Pfizer position peaked at $793K in Q4 2021.
- 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.
Based on Mayfair Advisory Group's 13F filing for Q3 2025, filed 21 Oct 2025.